Press release
Psychedelic Drugs Industry is Expected to Reach $ 9.9 billion by 2031 - Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/psychedelic-drugs-market
The Psychedelic Drugs market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
Psychedelic drugs are substances that alter perception, mood, and cognitive processes, often leading to changes in sensory experiences and thought patterns. These drugs, such as LSD, psilocybin (magic mushrooms), and DMT, work primarily by affecting serotonin receptors in the brain. Psychedelics can induce profound psychological experiences, often referred to as "trips," which can include hallucinations, altered sense of time, and deep introspection. While some psychedelics are being studied for their potential therapeutic benefits in treating conditions like depression and PTSD, they also carry risks of psychological distress and impaired judgment.
Forecast Growth Projected:
The Global Psychedelic Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Psychedelic Drugs Market:
Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings Ltd, and GH Research PLC
Segment Covered in the Psychedelic Drugs Market:
By Drug Type: Lysergic Acid Diethylamide, Gamma Hydroxybutyric Acid, Ketamine, Psilocybin, Others
By Application: Treatment-Resistant depression, Post- Traumatic stress disorder, Narcolepsy, Panic Disorders, Others
By Distribution Channel: Hospital Pharmacies, Retail pharmacies, Online Pharmacies
Regional Analysis:
The global Psychedelic Drugs Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/psychedelic-drugs-market
Regional Analysis:
The global Psychedelic Drugs Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Psychedelic Drugs Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Psychedelic Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Psychedelic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/psychedelic-drugs-market
FAQs
How big is the Psychedelic Drugs Market?
The Psychedelic Drugs Market size was USD 3.9 billion in 2023. It is expected to reach USD 9.9 billion by 2031.
How fast is the Psychedelic Drugs Market growing?
The Psychedelic Drugs Market will exhibit a CAGR of 12.6% during the forecast period, 2024-2031.
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psychedelic Drugs Industry is Expected to Reach $ 9.9 billion by 2031 - Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc here
News-ID: 3591721 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Artificial Intelligence in Healthcare Market to Reach USD 187.7 Bi …
Artificial Intelligence in Healthcare Market Overview
The Global Artificial Intelligence (AI) in Healthcare Market reached USD 13,248.65 million in 2022 and is projected to grow significantly, reaching USD 187,704.75 million by 2031, expanding at an impressive CAGR of 41.1% during 2024-2031. The market's rapid growth is driven by the increasing integration of AI technologies across various aspects of healthcare, from clinical diagnosis and imaging to drug discovery, patient monitoring, and hospital…
United States Smart Syringe Market 2033 | Growth Drivers, Key Players & Investme …
Market Size and Growth
Smart Syringe Market reached US$ 12.22 Billion in 2024 and is expected to reach US$ 25.97 Billion by 2033, growing at a CAGR of 8.8% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/smart-syringe-market?sb
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Apiject Systems, Corp. submitted a regulatory filing to the U.S. Food and Drug Administration…
United States Bovine Colostrum Market to Reach $5.19 Billion by 2031, Driven by …
Leander, Texas and TOKYO, Japan - Dec.10.2025
Market Size
As per DataM Intelligence research report, "The Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2031, growing at a CAGR of 6.21% during the forecast period 2024-2031." Rising awareness of immune-boosting supplements and increasing demand for functional dairy products are driving market growth.
Download your exclusive sample report today: (corporate email gets priority…
United States Tungsten-Based Materials Market 2031 | Growth Drivers, Key Players …
Market Size and Growth
Global Tungsten-Based Materials Market reached US$ 5.9 billion in 2023 and is expected to reach US$ 9.4 billion by 2031, growing with a CAGR of 6.1% during the forecast period 2024-2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/tungsten-based-materials-market?sb
Key Development:
United States: Recent Developments
✅ In November 2025, Global Tungsten & Powders was awarded a grant by the U.S. Department of Energy…
More Releases for Psychedelic
Psychedelic Therapeutics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Psychedelic Therapeutics Market By Origin of Psychedelic Substance (Synthetic Substances and Natural Substances), Type of Psychedelic Substance (GHB, Ketamine, MDMA, Psilocybin, DMT, Ayahuasca and LSD), Target Therapeutic Area (Depression and Anxiety Disorders, Pain Disorders, Sleep-Related Disorders and Trauma)- Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
Ibogaine by David Dardashti Forges Strategic Partnership with Psychedelic Univer …
MIAMI, FL - June 20, 2025 - Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects to be explored at the highly anticipated Psychedelic Conference 2025. The initiative is further…
Psychedelic Drugs Market Growth, Status & Opportunities 2034
On March 21, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Psychedelic Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
The Psychedelic Drugs Market: Exploring the Therapeutic Potential
The psychedelic drugs market is undergoing a significant resurgence, driven by a renewed interest in their potential therapeutic applications. After decades of legal restrictions and limited research, these substances are now being investigated for their potential to treat a range of mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and addiction. This post will delve into the market, exploring its size, share, opportunities, challenges, demand, and trends.
Market Size…
Psychedelic Drugs Market Size, Overview & Leading 2024-2033
The new report published by The Business Research Company, titled ""Psychedelic Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the psychedelic drugs market size has grown rapidly in recent years. It will grow from $4.88 billion in…
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH …
PSYCHEDELIC CHURCH SOUL TRIBES INTERNATIONAL MINISTRIES PRESENTS "SHROOM BREATH 369" - A TRANSFORMATIONAL PSYCHEDELIC HEALING EXPERIENCE
DETROIT, MICHIGAN -- Psychedelic Church Soul Tribes International Ministries ("Soul Tribes" or the "Organization"), a 508(c)(1)(a) non-profit dedicated to psychedelic therapy and spiritual healing, announces its upcoming event, "Shroom Breath 369," on February 3rd, 2024, at the esteemed St. Regis in Detroit, Michigan.
Title: Shroom Breath 369 - A Psychedelic Healing Experience
Date: February 3rd, 2024
Time: 6:00…
